July 27, 2018
Rose
But the company is on the look-out for its next blockbuster as Revlimid will face market competition in coming years. Meanwhile, advocate groups ask for insurance commissioners will investigate the growing use of copay accumulators.
from Kaiser Health News https://ift.tt/2LMjnfM
July 27, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Experts Know What Doesn’t Work When It Comes To Controlling Health Costs, But Are Less Certain About What Will- Under Proposed California Bill, State Would Set Prices For Certain Health Care Services
- Health Scholars Criticize Medicaid Work Requirements, Saying Policy Contradicts Intent Of Program
- Scientists Want To Focus On Actual Brain Changes And Not Memory Loss As Way Of Defining Alzheimer’s
- Kaiser Permanente Launches $2 Million, Nationwide Initiative To Research Gun Violence
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment